Old Web
English
Sign In
Acemap
>
Paper
>
Outcomes of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Included in Phase I Clinical Trials
Outcomes of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Included in Phase I Clinical Trials
2018
Marion Brault
Maxime Annereau
Alina Danu
Julien Lazarovici
Claude Chahine
Andrea Varga
Capucine Baldini
Stéphane Champiat
Malik Berhoune
Christophe Massard
Francois Lemare
Vincent Ribrag
Jean-Marie Michot
Keywords:
Clinical trial
Oncology
Refractory Diffuse Large B-Cell Lymphoma
Medicine
Internal medicine
Immunology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]